Featured Articles

  • Zero Hour for Nitrosamine Compliance

    The FDA deadline to meet nitrosamine control guidance is upon us. Here’s a review of past nitrosamine-related regulatory actions — and lessons learned. read more

  • When Patient Insight Meets Smart Drug Formulation

    More than an ambition or just another formulation strategy, patient-centric drug design is the future of pharma. As emerging technologies make gathering and implementing user feedback simpler than ever, historical barriers to progress are falling away. read more

  • Coloring the Truth

    While colors are up for interpretation, science generally is not. Health misinformation has always existed, but took centerstage during the pandemic when social media quickly became a powerful tool for disseminating false narratives and blurry science. read more

  • Crossing the Red Line

    The first federal ban on a synthetic color due to the outdated Delaney Clause has inked a line in the sand — and crossing it could push the industry past the threshold of science-driven formulation into an era ruled by consumer perception based on misinformation. read more
  • <<
  • >>

Browse Products